The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gibbs Michael Terrence since 2017.
This trader's CIK number is 1665000.
At the time of last reporting, Gibbs Michael Terrence was the General Counsel of T2 Biosystems, Inc.. (stock ticker symbol TTOO).
Also see all insider trading activities at T2 Biosystems, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | TTOO | 0 | $0 | 0 | $0 | 69 | $0 |
| 2023 | TTOO | 0 | $0 | 3,969 | $2,443 | 7,247 | $0 |
| 2022 | TTOO | 10,000 | $4,900 | 0 | $0 | 172,385 | $0 |
| 2021 | TTOO | 0 | $0 | 16,038 | $28,658 | 26,667 | $0 |
| 2020 | TTOO | 0 | $0 | 12,291 | $10,115 | 15,833 | $0 |
| 2019 | TTOO | 0 | $0 | 5,764 | $19,556 | 18,834 | $0 |
| 2018 | TTOO | 0 | $0 | 2,202 | $9,424 | 24,086 | $0 |
| 2017 | TTOO | 1,000 | $3,510 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-24 | TTOO | Option Ex | 29 | .00 | 0 |
| 2024-02-20 | TTOO | Option Ex | 40 | .00 | 0 |
| 2023-03-28 | TTOO | Sale | 239 | .48 | 114 |
| 2023-03-24 | TTOO | Option Ex | 333 | .00 | 0 |
| 2023-02-20 | TTOO | Option Ex | 4,000 | .00 | 0 |
| 2023-02-28 | TTOO | Sale | 1,585 | .59 | 935 |
| 2023-02-24 | TTOO | Option Ex | 2,914 | .00 | 0 |
| 2023-02-22 | TTOO | Sale | 2,145 | .65 | 1,394 |
| 2022-04-07 | TTOO | Buy | 10,000 | .49 | 4,900 |
| 2022-03-24 | TTOO | Option Ex | 16,666 | .00 | 0 |
| 2022-02-24 | TTOO | Option Ex | 145,719 | .00 | 0 |
| 2022-02-21 | TTOO | Option Ex | 10,000 | .00 | 0 |
| 2021-03-25 | TTOO | Sale | 8,758 | 1.56 | 13,662 |
| 2021-03-24 | TTOO | Option Ex | 16,667 | .00 | 0 |
| 2021-02-21 | TTOO | Option Ex | 10,000 | .00 | 0 |
| 2021-02-23 | TTOO | Sale | 7,280 | 2.06 | 14,996 |
| 2020-02-24 | TTOO | Sale | 5,808 | .82 | 4,762 |
| 2020-02-21 | TTOO | Option Ex | 10,000 | .00 | 0 |
| 2020-02-11 | TTOO | Sale | 3,200 | .77 | 2,464 |
| 2020-02-09 | TTOO | Option Ex | 5,833 | .00 | 0 |
| 2020-02-03 | TTOO | Sale | 3,283 | .88 | 2,889 |
| 2019-02-11 | TTOO | Sale | 3,005 | 3.36 | 10,096 |
| 2019-02-09 | TTOO | Option Ex | 5,834 | .00 | 0 |
| 2019-01-31 | TTOO | Sale | 939 | 3.35 | 3,145 |
| 2018-11-30 | TTOO | Option Ex | 6,500 | .00 | 0 |
| 2017-11-30 | TTOO | Option Ex | 6,500 | .00 | 0 |
| 2019-02-01 | TTOO | Sale | 1,820 | 3.47 | 6,315 |
| 2018-06-28 | TTOO | Option Ex | 24,086 | .00 | 0 |
| 2018-02-09 | TTOO | Sale | 2,202 | 4.28 | 9,424 |
| 2017-06-06 | TTOO | Buy | 1,000 | 3.51 | 3,510 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gibbs Michael Terrence (General Counsel of T2 Biosystems, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.